Diagnostic value of ischemia-modified albumin in acute coronary syndrome and acute ischemic stroke

Basit Öğe Kaydı
dc.contributor.authorErtekin, Birsen
dc.contributor.authorKocak, Sedat
dc.contributor.authorDundar, Zerrin Defne
dc.contributor.authorGirisgin, Sadik
dc.contributor.authorCander, Basar
dc.contributor.authorGul, Mehmet
dc.contributor.authorDoseyici, Sibel
dc.date.accessioned2024-02-23T14:29:13Z
dc.date.available2024-02-23T14:29:13Z
dc.date.issued2013
dc.departmentNEÜen_US
dc.description.abstractObjective: To investigate diagnostic value of ischemia-modified albumin (IMA) levels in patients applying to emergency with symptoms of acute coronary syndrome (ACS) and acute ischemic stroke (AIS). Methods: Two patient groups (ACS and AIS) and a control group were constituted. The study was discontinued upon reaching 30 patients in each group. Following patient approval at the initial visit, a total of 10 ml venous blood sample was obtained from all patients with a high clinical suspicion of ACS and AIS. The Troponin I and the IMA levels were determined in the blood samples. Results: Statistically significant higher IMA values were determined in the patient groups compared to the control group (p < 0.001 for both groups). No statistically significant correlation was found between the IMA and the Troponin I values in the ACS and the AIS groups (p>0.05 for both groups). The sensitivity of IMA was 83% and 87% for ACS and AIS, respectively. The specificity of IMA was 90% and 87% for ACS and AIS, respectively. Conclusion: The sensitivity and specificity values, determined according to the optimal cut-off values in the groups demonstrated that IMA could be a useful diagnostic marker in ACS and AIS patients.en_US
dc.description.sponsorshipScientific Investigation Projects Directorate of Selcuk University, Konya, Turkeyen_US
dc.description.sponsorshipScientific Investigation Projects Directorate of Selcuk University, Konya, Turkey.en_US
dc.identifier.doi10.12669/pjms.294.3176
dc.identifier.endpage1007en_US
dc.identifier.issn1682-024X
dc.identifier.issue4en_US
dc.identifier.pmid24353676en_US
dc.identifier.scopus2-s2.0-84878928645en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage1003en_US
dc.identifier.urihttps://doi.org/10.12669/pjms.294.3176
dc.identifier.urihttps://hdl.handle.net/20.500.12452/14611
dc.identifier.volume29en_US
dc.identifier.wosWOS:000322619000023en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherProfessional Medical Publicationsen_US
dc.relation.ispartofPakistan Journal Of Medical Sciencesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectIschemiaen_US
dc.subjectIschemia-Modified Albuminen_US
dc.subjectEmergency Medicineen_US
dc.subjectAcute Coronary Syndromeen_US
dc.subjectAcute Ischemic Strokeen_US
dc.titleDiagnostic value of ischemia-modified albumin in acute coronary syndrome and acute ischemic strokeen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu